Legacy effect of fibrate add-on therapy in diabetic patients with dyslipidemia: a secondary analysis of the ACCORDION study

Legacy effect of fibrate add-on therapy in diabetic patients with dyslipidemia: a secondary analysis of the ACCORDION study

Abstract Background The Action to Control Cardiovascular Risk in Diabetes (ACCORD)-Lipid study found no evidence of a beneficial effect of statin-fibrate combined treatment, compared to statins alone, on cardiovascular outcomes and mortality in type 2 diabetes mellitus after 5 years of active treatm...

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar: Lin Zhu, Andrew Hayen, Katy J. L. Bell
Materyal Türü: Makale
Dil:English
Baskı/Yayın Bilgisi: BMC 2020-03-01
Seri Bilgileri:Cardiovascular Diabetology
Konular:
Fibrate
Dyslipidemia
Type 2 diabetes
Cardiovascular diseases
Legacy effect
Online Erişim:http://link.springer.com/article/10.1186/s12933-020-01002-x

Internet

http://link.springer.com/article/10.1186/s12933-020-01002-x

Benzer Materyaller